Clinical Trials Sponsored by Cellular Therapeutics

Total 6360 results

Innovative Cellular Therapeutics Inc.

Recruiting

GCC19CART for Patients With Metastatic Colorectal Cancer (CARAPIA-1)

Colorectal Cancer

United States
Innovative Cellular Therapeutics Co., Ltd.

Unknown

Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies

Lymphoma, B-Cell | Leukemia, B-Cell

China
Zhejiang University
Innovative Cellular Therapeutics Co., Ltd.

Unknown

CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma

Lymphoma

China
The Methodist Hospital Research Institute
Cellular Therapeutics

Completed

Efficacy and Safety Study of Xyotax to Treat Prostate Cancer

Prostatic Neoplasms

United States
TCA Cellular Therapy

Completed

Phase II Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia (MESENDO)

Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia | Severe Leg Ischemia

United States
Innovative Cellular Therapeutics Co., Ltd.
Anhui Provincial Cancer Hospital

Not yet recruiting

CART Therapy in Digestive System Tumors

Malignant Neoplasms of Digestive Organs

China
TCA Cellular Therapy

Suspended

Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury

Spinal Cord Injury

United States
TCA Cellular Therapy

Suspended

Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI)

Coronary Artery Disease | Coronary Disease | Heart Disease | Coronary Atherosclerosis | Coronary Ischemia | Blocked Arteries

United States
TCA Cellular Therapy

Suspended

Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
TCA Cellular Therapy

Completed

Combination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium

Coronary Artery Disease | Coronary Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis

United States
TCA Cellular Therapy

Completed

Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia (mesendo)

Peripheral Vascular Disease | Critical Limb Ischemia

United States
TCA Cellular Therapy

Completed

Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia (CI)

Coronary Artery Disease | Coronary Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis | Coronary Ischemia

United States
Weijia Fang, MD
Innovative Cellular Therapeutics Co., Ltd.

Completed

CART Therapy in GUCY2C-positive Digestive Tract Tumors (CART)

Malignant Neoplasms of Digestive Organs

China
Intra-Cellular Therapies, Inc.

Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder

United States
Cellular Biomedicine Group Ltd.

Recruiting

A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma (ELEVATION)

Relapsed/Refractory Large B-Cell Lymphoma

China
Intra-Cellular Therapies, Inc.

Recruiting

Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

Parkinson Disease

United States
Intra-Cellular Therapies, Inc.

Active, not recruiting

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

Schizophrenia

United States, Poland, Bulgaria, Serbia
Intra-Cellular Therapies, Inc.

Enrolling by invitation

An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Czechia, Slovakia, Germany, Hungary, Poland, Finland, India, Korea, Republic of, Sweden
Intra-Cellular Therapies, Inc.

Completed

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Bipolar Depression

Russian Federation, Ukraine, United States, Bulgaria, Serbia
Intra-Cellular Therapies, Inc.

Completed

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Bipolar Depression | Major Depressive Disorder

United States, Bulgaria, Russian Federation, Serbia, Ukraine
Intra-Cellular Therapies, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Pediatric

United States
Mynosys Cellular Devices, Inc.

Completed

A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System

Cataract
Intra-Cellular Therapies, Inc.

Completed

Study of a Novel Antipsychotic ITI-007 in Schizophrenia

Schizophrenia

United States
Intra-Cellular Therapies, Inc.

Completed

Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Czechia, Slovakia, Hungary, India
Intra-Cellular Therapies, Inc.

Active, not recruiting

Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Germany, Poland, Finland, Sweden, Argentina
Intra-Cellular Therapies, Inc.

Terminated

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Agitation in Dementia, Including Alzheimer's Disease

United States
Intra-Cellular Therapies, Inc.

Completed

Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure

Heart Failure, Systolic

United States
Intra-Cellular Therapies, Inc.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease

Parkinson Disease

United States
Intra-Cellular Therapies, Inc.

Completed

Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia

Alzheimer's Disease

United States
Intra-Cellular Therapies, Inc.

Completed

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

Schizophrenia

United States
Intra-Cellular Therapies, Inc.

Completed

Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia

Schizophrenia

United States
Emphycorp
Cellular Sciences, inc.

Completed

Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.

Cystic Fibrosis

United States
Intra-Cellular Therapies, Inc.

Recruiting

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Bipolar Depression

United States
Intra-Cellular Therapies, Inc.

Not yet recruiting

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

Healthy Volunteers

United States
Cellular Biomedicine Group Ltd.

Not yet recruiting

Allogenic Adipose-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis

Knee Osteoarthritis

China
Intra-Cellular Therapies, Inc.

Recruiting

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Cellular Biomedicine Group Ltd.

Recruiting

A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

China
Intra-Cellular Therapies, Inc.

Completed

Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia

Schizophrenia

United States
Intra-Cellular Therapies, Inc.

Completed

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Bipolar Depression

United States, Russian Federation, Ukraine, Bulgaria, Serbia, Colombia
Intra-Cellular Therapies, Inc.

Completed

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Bipolar Depression

United States
Intra-Cellular Therapies, Inc.

Completed

A Trial to Assess the Antipsychotic Efficacy of ITI-007

Schizophrenia

United States
Emphycorp
Cellular Sciences, inc.

Completed

Sodium Pyruvate Therapy in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
Novo Cellular Medicine Institute LLP

Unknown

A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Multiple Sclerosis, Relapsing-Remitting

Trinidad and Tobago
Takeda
Intra-Cellular Therapies, Inc.

Terminated

Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia

Schizophrenia

United States
Novo Cellular Medicine Institute LLP

Unknown

A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Multiple Sclerosis, Relapsing-Remitting

India, Trinidad and Tobago
Ruijin Hospital
Cellular Biomedicine Group Ltd.

Unknown

A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS

Acute Respiratory Distress Syndrome

China
Ruijin Hospital
Cellular Biomedicine Group Ltd.

Completed

A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers

Healthy

China
Cellular Biomedicine Group Ltd.
Fudan University

Unknown

Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC

Metastatic Castration-resistant Prostate Cancer

China
University of Minnesota
Cellular Sciences, inc.

Terminated

A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.

Cystic Fibrosis

United States
Ruijin Hospital
Cellular Biomedicine Group Ltd.

Recruiting

A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection

Drug-resistant

China

Clinical Trials Sponsored by Cellular Therapeutics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations